Sequential combination of mitomycin C plus bacillus calmette-guérin (BCG) is more effective but more toxic than BCG alone in patients with non-muscle-invasive bladder cancer in intermediate- and high-risk patients: Final outcome of CUETO 93009, a randomized prospective trial

1. Solsona, E.
2. Madero, R.
3. Chantada, V.
4. Fernandez, J.M.
5. Zabala, J.A.
6. Portillo, J.A.
7. Alonso, J.M.
8. Astobieta, A.
9. Unda, M.
10. Martinez-Piñeiro, L.
11. Rabadan, M.
12. Ojea, A.
13. Rodriguez-Molina, J.
14. Beardo, P.
15. Muntañola, P.
16. Gomez, M.
17. Montesinos, M.
18. Martinez Piñeiro, J.A.